Registration
 
All news
Top Stories
Editors' Picks
Stocks
Crypto
Economics
Currencies
Commodities
Business & Wealth
Market Voices
Eugene Komchuk
Eugene Komchuk

Definium Therapeutics reports positive Phase 3 Panorama results for DT120 ODT in GAD

Definium Therapeutics reports positive Phase 3 Panorama results for DT120 ODT in GAD
Definium posts third positive Phase 3

Definium Therapeutics has announced positive topline results from its Phase 3 Panorama study evaluating DT120 ODT for generalized anxiety disorder (GAD).

The company highlighted that this follows a successful readout from its earlier Voyage study, marking the third positive Phase 3 trial and a significant milestone in its clinical development efforts for GAD therapies.

Definium Therapeutics has recently focused on advancing mental health treatments. In September, the company engaged investors to expand scientific progress in the sector, as reported in its mental health innovation initiatives. The latest Phase 3 trial results mark another step in its clinical pipeline for generalized anxiety disorder.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.

Editor's Picks for You

Adobe and AI: Is the creative software giant losing its edge?
  • By Dmytro Kharkov
  • 1 hour ago
Adobe and AI: Is the creative software giant losing its edge?
Editors' Picks
Solana vs. Base: Who will dominate the token launch market?
  • By Pavlo Kot
  • Yesterday
Solana vs. Base: Who will dominate the token launch market?
Editors' Picks
Jobs in crypto: Which specialists are in demand now?
  • By Pavlo Kot
  • 17.10.2026
Jobs in crypto: Which specialists are in demand now?
Editors' Picks
All Editors' Top Picks

Latest Definium News

Definium Therapeutics advances Phase 3 trials for DT120 in major depressive disorder and anxiety
  • By Mikhail Vnuchkov
  • 13.10.2026
Definium Therapeutics advances Phase 3 trials for DT120 in major depressive disorder and anxiety
Companies
#Definium
Definium Therapeutics secures top poster award at PsychCongress for DT120 Phase 3 results
  • By Yaroslav Dmytrenko
  • 22.09.2026
Definium Therapeutics secures top poster award at PsychCongress for DT120 Phase 3 results
Companies
#Definium
Definium Therapeutics targets accelerated progress in mental health innovations at September investor events
  • By Eugene Komchuk
  • 26.08.2026
Definium Therapeutics targets accelerated progress in mental health innovations at September investor events
Companies
#Definium
All Definium News
  • Dmytro Kharkov
  • 1 hour ago
Adobe and AI: Is the creative software giant losing its edge?
  • Pavlo Kot
  • Yesterday
Solana vs. Base: Who will dominate the token launch market?
  • Pavlo Kot
  • 17.10.2026
Jobs in crypto: Which specialists are in demand now?
  • Anastasiia Chabaniuk
  • 16.10.2026
Poland's crypto paradox: A growing market caught in regulatory deadlock
  • Eugene Komchuk
  • 16.10.2026
Jimmy Song: Trump has failed to meet Bitcoiners' expectations
  • Yaroslav Dmytrenko
  • 38 min ago
WTI refining margins fall sharply to $55 a barrel, Javier Blas notes
  • Eugene Komchuk
  • 1 hour ago
Robert Peston: UK creditors and investors may be too harsh, he says
  • Daria Chernytska
  • 2 hours ago
Sumit Gupta: India collected ₹1,096 crore in crypto TDS from FY22-23 to FY24-25
  • Alena Volkova
  • 2 hours ago
Anyone with over €30,000 in assets faces 36 percent tax, Jeroen Blokland notes
  • Alena Volkova
  • 3 hours ago
$500 ONDO perps prize to five people, Kevin Susanto states
Top News
  • Ivan Andriyenko
  • 27 min ago
Gold rises above $4,180 as investors reassess Fed policy outlook
Gold rises above $4,180 as investors reassess Fed policy outlook
  • Dmytro Kharkov
  • 1 hour ago
Adobe and AI: Is the creative software giant losing its edge?
Adobe and AI: Is the creative software giant losing its edge?
  • Andrey Mastykin
  • 1 hour ago
CXMT shares drop 7% despite forecast profit turnaround
CXMT shares drop 7% despite forecast profit turnaround
  • Olga Shendetskaya
  • 2 hours ago
Oil prices tumble as Russian export prospects outweigh Gulf shipping risks
Oil prices tumble as Russian export prospects outweigh Gulf shipping risks
  • Eugene Komchuk
  • 2 hours ago
Qubic blockchain halts operations after $1.4 million crypto theft
Qubic blockchain halts operations after $1.4 million crypto theft
Live News
  • Mykhailo Ihnatenko
  • Now
Ethereum price prediction: Can ETH break $2,440 before another liquidation wave?
  • Eugene Komchuk
  • Now
Circle plans to expand USDC into 40 new markets
  • Hanna Syniavska
  • Now
Shell plans to sell French mobility assets to DCC Energ
  • Anton Kharitonov
  • Now
EUR/USD holds above 1.1260 as falling U.S. yields overshadow sticky inflation
  • Mykhailo Ihnatenko
  • Now
Tesla stock climbs over 4% after high-profile Roadster presentation
Who We Are
Business Solutions
For Users
TU News
Popular Sections
Disclosures
CONTACT US
Legal
We are in Social Media
© IAFT Ltd., 2010-2026 All rights to the website are owned by IAFT Ltd.,
Registration number - HE 336186
  • Risk disclosure:

    Information on the TradersUnion.com website is for informational purposes only and does not constitute any motive or suggestion to visitors to invest money. Moreover, we hereby warn you that trading on the Forex and CFD markets is always a high risk. According to the statistics, 75-89% of customers lose the funds invested and only 11-25% of traders earn a profit. Trading in futures and options carries substantial risk of loss and is not suitable for every investor.

    That is why you should only invest money that you are prepared — or can afford — to lose at such high risks. Tradersunion.com does not provide any financial services, including investment or financial advisory services. Also, the Traders Union is not a broker and does not get money for trading in the Forex or CFD markets. Our website only provides information on brokers and the markets and helps its users to select the best brokerage company based on detailed information and objective analysis of brokers.

  • Disclaimer:

    Traders Union (TradersUnion.com) shall not be liable for the consequences of trading decisions made by the Client and for the possible loss of his capital resulting from the use of this website and information published on it.

    Forex market, CFD and cryptocurrency trading involves high risks and is not suitable for everyone. Before investing money, you need to adequately assess the level of your expertise and be aware of the risks, particularly in the context of trading with leverage. The information on this website is not intended for distribution or use by any person in any country or jurisdiction, where such distribution or use would be in violation of the local law or regulation. Any payments by Traders Union (TradersUnion.com) to the users of our website shall be legally interpreted solely as an incentive on our part for the activity on the website in the form of a deduction of a part of the advertising income; they shall not be a subject of any claims of our users or our obligations, a subject of disputes, as well as cannot be considered in relation to the services provided to users by brokers, both in fact and in their completeness and volume. The administration of the website shall not be liable for the content of user comments and reviews about the companies and shall not verify whether the authors of the reviews are indeed real clients of a specific company. All reviews, both negative and positive are published on the website without verification of their reliability; only offensive reviews that call for violence or any kind of discrimination and also reviews published from one group of IP addresses are moderated and removed. The authors of the materials shall be fully liable for the accuracy, completeness and impartiality of any information in the articles and reviews, including in the context of their use or mention of any brand names or trademarks. All mentions of the names of companies and their brands in any materials on the website shall be made in the context of communication of socially important information to the people about their activities by independent journalists, who are the authors. All evaluations and indicators on the website express the subjective opinion of the authors of the reviews (articles) and shall not be viewed as accurate statements and be a subject of disputes and claims against Traders Union.

  • Disclosure of advertisers and revenues:

    All the services on the Tradersunion.com website are free for you to use. Our team spends thousands of hours per annum researching brokers and gathering information about them to help investors all over the world to choose reliable companies and to avoid fraudsters.

    Indeed, the curating, sourcing, and organization of this process requires substantial financial investment by Tradersunion.com, which the website earns in the form of advertising payments. There are two types of advertising services on the website — direct advertising or partner (broker) participation programs. However, no services purchased by our partners shall affect the recommendations on our website, or our opinions, or ratings. Our ratings are based on our objective rating criteria and methodology; and the results are always equally and fairly applied to each broker. The work of our content authors and research groups does not involve any interaction with our advertisers and they do not have access to data concerning the amount of advertising purchased. For over 10 years we consider our independence, absolute openness, and objectivity as our main priority. Please follow the links to each of our affiliated broker’s websites. This will help Tradersunion.com to continue to provide our services to you for free.

onepercentfortheplanet.org https://gdpr.eu/ GDPR World Association of News Publishers